![Connie Swanson](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Connie Swanson
Nessuna posizione attualmente
Provenienza dei contatti di primo grado di Connie Swanson
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Shionogi Pharma, Inc.
![]() Shionogi Pharma, Inc. Pharmaceuticals: MajorHealth Technology Shionogi Pharma, Inc. manufactures pharmaceuticals. The company is headquartered in Alpharetta, GA.
6
| Subsidiary | Pharmaceuticals: Major | 6 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Connie Swanson tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
INCYTE CORPORATION | Pharmaceuticals: Major | Director/Board Member | |
ID Biomedical Corp.
![]() ID Biomedical Corp. Medical SpecialtiesHealth Technology ID Biomedical Corp. develops gene-based disease testing and subunit vaccines. It conducts research, development, manufacturing, sales, and marketing from its facilities in Canada and in the United States. The company was founded in 1991 and is headquartered in Vancouver, Canada. | Medical Specialties | Director/Board Member | |
Carnegie Mellon University
![]() Carnegie Mellon University Other Consumer ServicesConsumer Services Carnegie Mellon University is an American school that operates as a college or university. It is located in Pittsburgh, Pennsylvania. | College/University | Undergraduate Degree | |
QUESTCOR PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member | |
DURECT CORPORATION | Pharmaceuticals: Major | Director/Board Member | |
K2X TECHNOLOGY & LIFE SCIENCE, INC. | Pharmaceuticals: Major | Director/Board Member | |
Trellis Bioscience, Inc.
![]() Trellis Bioscience, Inc. BiotechnologyHealth Technology Trellis Bioscience, Inc. is discovers and develops novel human antibody therapeutics. It provides the discovery and development of therapeutic antibodies from human B cells. The firm develops the CellSpot antibody discovery platform, which enables the identification of antibodies directly from human blood. The company was founded by Lawrence Kauvar and Stote Ellsworth in 1998 and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member | |
BaroFold, Inc.
![]() BaroFold, Inc. Pharmaceuticals: MajorHealth Technology BaroFold, Inc. develops and commercializes protein therapeutics. Its services include protein refolding, protein analytical and aggregate characterization, formulation stability and immunogenicity studies, and microbial expression. The company was founded by Matthew Seefeldt, Matthew Brewer, John F. Carpenter, Ted Randolph, Timothy C. Rodell, and Lyndal K. Hesterberg in 2009 and is headquartered in Aurora, CO. | Pharmaceuticals: Major | Director/Board Member | |
Arbor Vita Corp.
![]() Arbor Vita Corp. Miscellaneous Commercial ServicesCommercial Services Arbor Vita Corp. engages in discovery and developing of drugs. It targets cellular regulators, PDZ proteins, to accelerate the discovery and development of human therapeutics, and diagnostics. The company was founded by Peter S. Lu in 1998 and is headquartered in Fremont, CA. | Miscellaneous Commercial Services | Director/Board Member | |
Entelos, Inc.
![]() Entelos, Inc. Information Technology ServicesTechnology Services Entelos, Inc. develops predictive computer models of human disease. Its solutions include mechanism-based, mathematical models; virtual patients, populations; biosimulation software and biosimulation expertise. The company was founded in 1996 and is headquartered in San Mateo, CA. | Information Technology Services | Chairman | |
CANCER PREVENTION PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member | |
Achelios Therapeutics, Inc.
![]() Achelios Therapeutics, Inc. BiotechnologyHealth Technology Achelios Therapeutics, Inc. operates as a bio-pharmaceutical development company. It specializes in non-steroidal anti-inflammatory drug. The company was founded by Crist J. Frangakis and is headquartered in Chaple Hill, NC. | Biotechnology | Director/Board Member | |
Institutional Venture Partners
![]() Institutional Venture Partners Investment ManagersFinance Institutional Venture Partners (Institutional Venture Partners) is a venture capital firm founded in 1980 by Reid Dennis. The firm is headquartered in Menlo Park, California. | Investment Managers | Corporate Officer/Principal | |
Hoffmann-La Roche, Inc.
![]() Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | General Counsel | |
Dialysis Centers of America, Inc.
![]() Dialysis Centers of America, Inc. Medical/Nursing ServicesHealth Services Part of Fresenius Medical Care AG, Dialysis Centers of America, Inc. is a company that operates 12 dialysis centers. The company is based in Chicago, IL. Dialysis Centers of America was acquired by Renal Care Group, Inc., part of Fresenius Medical Care AG from January 03, 2007 on February 03, 1999 for $90.82 million. | Medical/Nursing Services | Director of Finance/CFO | |
Kennesaw State University | College/University | Masters Business Admin | |
Walsh College | College/University | Undergraduate Degree | |
PDL BIOPHARMA, INC. | Biotechnology | President | |
Alaven Pharmaceutical LLC
![]() Alaven Pharmaceutical LLC Medical DistributorsDistribution Services Alaven Pharmaceutical LLC develops and markets prescription and non-prescription products. The company was founded on August 01, 2003 and is headquartered in Somerset, NJ. | Medical Distributors | Chief Executive Officer Director of Finance/CFO | |
Grady Memorial Hospital
![]() Grady Memorial Hospital Hospital/Nursing ManagementHealth Services Grady Memorial Hospital operates a hospital. The private company is based in Delaware, OH. John M. Haupert has been the CEO of the company since 2011. | Hospital/Nursing Management | Corporate Officer/Principal | |
Canada's Research Based Pharmaceutical Cos. | Director/Board Member | ||
Saxe Associates, Inc. | President | ||
A-CUBE, Inc.
![]() A-CUBE, Inc. BiotechnologyHealth Technology A-CUBE, Inc. develops novel antibodies. It utilizes silico algorithms and to discover novel druggable targets suitable for developing human therapeutic interventions, including next generation drugs for commercially proven targets. The company was founded by Nobuyuki Ota is headquartered in Belmont, CA. | Biotechnology | Director/Board Member | |
VistaGen, Inc. | Chairman | ||
Rhone-Poulenc Pharmaceuticals, Inc. | Chairman | ||
VISTAGEN THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Arcuo Medical, Inc.
![]() Arcuo Medical, Inc. Medical SpecialtiesHealth Technology Arcuo Medical, Inc. manufactures surgical and medical instruments. | Medical Specialties | Director/Board Member | |
Shionogi, Inc.
![]() Shionogi, Inc. Pharmaceuticals: MajorHealth Technology Part of Shionogi & Co., Ltd., Shionogi, Inc. is a pharmaceutical company based in Florham Park, NJ. Since 1878, the company has been utilizing science to address health challenges and has discovered several novel antibiotics and medications for HIV and influenza. Shionogi conducts ongoing research into established products and new antibiotic compounds, as well as developing an investigational antiviral for COVID-19. The company is committed to pursuing discovery through partnerships, including collaboration with scientists through investigator-initiated research. Shionogi is dedicated to advancing the greater good by developing, partnering, and commercializing medicine to treat serious unmet medical needs in infectious disease and other areas of high medical need including neurology and cardiovascular disease. Nathan McCutcheon has been the CEO of the company since 2019. | Pharmaceuticals: Major | Director/Board Member | |
Lumos Pharma Sub, Inc.
![]() Lumos Pharma Sub, Inc. Medical/Nursing ServicesHealth Services Lumos Pharma Sub, Inc. develops and commercializes a novel treatment for the rare disease creatine transporter deficiency. It focuses on bringing novel therapies to patients afflicted with unmet medical needs in severe, rare, and genetic diseases. The firm's technology LUM-001 is a repurposed small molecule that is a kinetically similar analog of creatine and has shown promising therapeutic potential for the treatment of creatine transporter deficiency. Lumos Pharma was founded by Richard J. Hawkins in 2010 and is headquartered in Austin, TX. | Medical/Nursing Services | Director/Board Member | |
Armetheon, Inc.
![]() Armetheon, Inc. Pharmaceuticals: MajorHealth Technology Armetheon, Inc. engages in medical development. It specializes in thrombosis and cardiac arrhythmias. The company was founded by Pascal J. Druzgala, Muralitharan Ken Kengatharan and Peter G. Milner in 2011 and is headquartered in Milpitas, CA. | Pharmaceuticals: Major | Director/Board Member | |
George Washington University Law School | College/University | Graduate Degree | |
New York University School of Law | College/University | Graduate Degree | |
Nuvox Pharma LLC
![]() Nuvox Pharma LLC Miscellaneous Commercial ServicesCommercial Services Nuvox Pharma LLC operates as biotechnology company. Its publication includes acute hypoxemic respiratory failure, hermorrrhagic shock, mechanism of action, myorcardial infarction, oncology, pharmacokinetics, stroke, and traumatic brain injury. The company was founded by Evan Unger and is headquartered in Tucson, AZ. | Miscellaneous Commercial Services | Director/Board Member | |
Epalex Corp.
![]() Epalex Corp. Miscellaneous Commercial ServicesCommercial Services Epalex Corp. engages in the development of novel treatments for migraine and epilepsy. The treatment for the first time provides a way for patients with epilepsy to gain control over their seizures. The firm also develops transformational products for seizure prophylaxis in patients suffering from primary generalized epilepsies. The company was founded Randall B. Murphy and is headquartered in Palo Alto, CA. | Miscellaneous Commercial Services | Chairman | |
Sciele Pharmaceuticals, Inc. | Director/Board Member Director/Board Member | ||
Aether, Inc. | Director/Board Member | ||
NuvOx Therapeutics, Inc.
![]() NuvOx Therapeutics, Inc. BiotechnologyHealth Technology NuvOx Therapeutics, Inc. is a clinical stage biotechnology company that develops oxygen therapeutics. The company is based in Tucson, AZ. NuvOx Therapeutics was founded by Jennifer Johnson, Evan C. Unger. Evan C. Unger has been the CEO since incorporation. | Biotechnology | Director/Board Member | |
Vytacera Pharma, Inc. | Chairman |
Statistiche
Distribuzione geografica
Stati Uniti | 47 |
Canada | 3 |
Regno Unito | 3 |
Settori
Health Technology | 27 |
Consumer Services | 6 |
Commercial Services | 4 |
Health Services | 4 |
Technology Services | 3 |
Posizioni
Director/Board Member | 45 |
Chairman | 17 |
Corporate Officer/Principal | 16 |
President | 9 |
Independent Dir/Board Member | 8 |
Contatti più connessi
Insiders | |
---|---|
Jon Saxe | 43 |
Pierre LaPalme | 21 |
Bala Venkataraman | 17 |
William G. Campbell | 7 |
R. Brent Dixon | 6 |
Jerry N. Ellis | 5 |
- Borsa valori
- Insiders
- Connie Swanson
- Connessioni Società